Skip to main content
. Author manuscript; available in PMC: 2015 Mar 4.
Published in final edited form as: Mol Biosyst. 2014 Jan 9;10(3):581–591. doi: 10.1039/c3mb70503j

Table 1.

Drugs that Exhibit High Selectivity and Preference to Oncology Targets

Drug Name Total
Cancer
targets
Total
Approved
Drugs
targets
CSI Targets
Isoetharine 4 1 4 β1 adrenergic receptor
Salbutamol 3 1 3 β1,2 adrenergic receptor
Guanadrel
sulfate
2 1 2 Sodium-dependent noradrenaline
transporter
Diatrizoate 4 2 2 N/A
Rimantadine 2 1 2 Influenza A virus matrix protein 2
Starvudine 2 1 2 HIV1 reverse transcriptase
Phensuximide 2 1 2 N/A
Diethylpropion 8 4 2 Sodium-dependent noradrenaline and
dopamine transporters
Bromfenac 12 6 2 COX1, 2
Methyprylon 2 1 2 γ-aminobutyric acid receptor subunit alpha-
1
Iophendylate 2 1 2 N/A
Methsuximide 10 5 2 Voltage-dependent T-type calcium channel